IL150225A0 - Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof - Google Patents

Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof

Info

Publication number
IL150225A0
IL150225A0 IL15022500A IL15022500A IL150225A0 IL 150225 A0 IL150225 A0 IL 150225A0 IL 15022500 A IL15022500 A IL 15022500A IL 15022500 A IL15022500 A IL 15022500A IL 150225 A0 IL150225 A0 IL 150225A0
Authority
IL
Israel
Prior art keywords
lipopeptides
production
methods
same
pharmaceutical compositions
Prior art date
Application number
IL15022500A
Other languages
English (en)
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of IL150225A0 publication Critical patent/IL150225A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL15022500A 1999-12-15 2000-12-15 Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof IL150225A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17094699P 1999-12-15 1999-12-15
US20822200P 2000-05-30 2000-05-30
PCT/US2000/034205 WO2001044274A1 (fr) 1999-12-15 2000-12-15 Lipopeptides utiles en tant qu'agents antibacteriens

Publications (1)

Publication Number Publication Date
IL150225A0 true IL150225A0 (en) 2002-12-01

Family

ID=26866577

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15022500A IL150225A0 (en) 1999-12-15 2000-12-15 Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof

Country Status (12)

Country Link
US (3) US7408025B2 (fr)
EP (1) EP1246838A1 (fr)
JP (1) JP2003517480A (fr)
KR (1) KR20020063228A (fr)
CN (1) CN1423656A (fr)
AU (1) AU784812B2 (fr)
BR (1) BR0016467A (fr)
CA (1) CA2394350A1 (fr)
IL (1) IL150225A0 (fr)
MX (1) MXPA02006030A (fr)
NO (1) NO20022887L (fr)
WO (1) WO2001044274A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
KR20110127732A (ko) 2000-12-18 2011-11-25 큐비스트 파마슈티컬즈 인코포레이티드 정제된 리포펩티드의 제조 방법
EP1932853A1 (fr) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Nouveaux depsipeptides et leur procédé de préparation
DE60232158D1 (de) * 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
WO2003103699A1 (fr) 2002-06-06 2003-12-18 Vicuron Pharmaceuticals Inc. Utilisation de ramoplanine pour traiter des troubles associes a la prise d'antibiotiques
WO2006004865A1 (fr) * 2004-06-29 2006-01-12 Rigel Pharmaceuticals, Inc. Composés de quinoléine de substitution et leurs utilisations comme inhibiteurs de la cascade de signalement du récepteur d'immunoglobuline (ige)
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
BRPI0514381A (pt) * 2004-07-30 2008-06-10 Palumed Sa compostos hìbridos de aminoquinolina-antibiótico, composições farmacêuticas, método de preparação e uso destes
JP2008519848A (ja) * 2004-11-12 2008-06-12 キュービスト ファーマシューティカルズ， インコーポレイテッド 抗感染性リポペプチド
US8968781B2 (en) 2005-04-29 2015-03-03 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US7964729B2 (en) 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
US8440835B2 (en) 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
EP2018864A1 (fr) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Composition pharmaceutique, substrat comprenant une composition pharmaceutique et utilisation d'une composition pharmaceutique
AU2009330245C1 (en) 2008-12-22 2013-09-26 Merck Sharp & Dohme Corp. Novel antibacterial agents for the treatment of gram positive infections
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8409820B2 (en) 2009-08-31 2013-04-02 Massachusetts Institute Of Technology Kinase sensors
RU2607526C2 (ru) 2009-11-23 2017-01-10 Кьюбист Фармасьютикалз ЭлЭлСи Липопептидные композиции и родственные способы
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2806362A1 (fr) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration de rifalazil a des patients immunodeprimes
WO2012027495A1 (fr) 2010-08-27 2012-03-01 University Of The Pacific Analogues de pipérazinylpyrimidine en tant qu'inhibiteurs de protéine kinase
US20120317234A1 (en) * 2011-06-09 2012-12-13 International Business Machines Corporation Managing data access in mobile devices
US8461188B2 (en) 2011-10-20 2013-06-11 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
US9165332B2 (en) * 2012-01-27 2015-10-20 Microsoft Technology Licensing, Llc Application licensing using multiple forms of licensing
US9348608B2 (en) * 2013-04-24 2016-05-24 QRC, Inc. System and method for registering application and application transforms on a radiofrequency digitization and collection device
CN105392780A (zh) * 2013-05-24 2016-03-09 雀巢产品技术援助有限公司 用于预测肠易激综合征诊断的途径特异性测定
CN104322562B (zh) * 2014-09-16 2017-04-26 南京农业大学 一种脂肽‑高岭土复合生防制剂及其制备方法和应用
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) * 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
EP3661946A4 (fr) * 2017-08-01 2021-04-21 Agency for Science, Technology and Research Peptidomimétiques à activité antimicrobienne
EP4117625A1 (fr) 2020-03-12 2023-01-18 Baxter International Inc. Formulations de daptomycine contenant une association de sorbitol et de mannitol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
DD238068A5 (de) * 1984-10-09 1986-08-06 ���@�����@�K@�������k�� Verfahren zur herstellung von derivaten der cyclopeptidantibiotika a-21978 c
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
DE69121018T2 (de) * 1990-06-07 1996-12-19 Lilly Co Eli Lipopeptid Deacylase
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0885957B1 (fr) 1996-03-08 2009-08-12 Astellas Pharma Inc. Processus de deacylation de lipopeptides cycliques
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
BR0017028A (pt) * 1999-12-15 2003-01-07 Cubist Pharm Inc Lipopepìdeos como agentes antibacterianos
IL150223A0 (en) * 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
MXPA02006030A (es) 2004-08-23
KR20020063228A (ko) 2002-08-01
AU784812B2 (en) 2006-06-29
CN1423656A (zh) 2003-06-11
US20080287347A1 (en) 2008-11-20
US20090011977A1 (en) 2009-01-08
EP1246838A1 (fr) 2002-10-09
NO20022887D0 (no) 2002-06-17
BR0016467A (pt) 2002-08-27
AU3635701A (en) 2001-06-25
CA2394350A1 (fr) 2001-06-21
US20040067878A1 (en) 2004-04-08
US7408025B2 (en) 2008-08-05
JP2003517480A (ja) 2003-05-27
NO20022887L (no) 2002-08-12
WO2001044274A1 (fr) 2001-06-21

Similar Documents

Publication Publication Date Title
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
HUP0203190A3 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0201900A3 (en) Bicyclic heterocycles, pharmaceutical compositions containing them, their use and methods for the production thereof
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL162185A0 (en) Phenylpropionate derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203496A3 (en) Novel cyclopropane derivatives, pharmaceutical compositions containing them and method for the production thereof
ZA200203486B (en) Novel pharmaceutical compositions.
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
IL154096A0 (en) Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL161428A0 (en) Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200928A3 (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
HK1038927A1 (en) (1-Phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
HUP0203310A3 (en) Stable pharmaceutical compositions comprising benzimidazol and method for the production thereof